Silencing of Cited2 and Akap12 genes in radiation-induced rat osteosarcomas

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 654-658

  Daino, Kazuhiro ^a   Roch Lefevre, Sandrine ^b   Ugolin, Nicolas ^a   Altmeyer Morel, Sandrine ^a   Guilly, Marie Noëlle ^a   Chevillard, Sylvie ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b SRBE   (France)

Author keywords

Ionizing radiation; Osteosarcoma; Tumor suppressor gene

Indexed keywords

ASPARTIC ACID; BETA ACTIN; GENE PRODUCT; GLUTAMIC ACID; MESSENGER RNA; PLUTONIUM 238; PROTEIN AKAP12; PROTEIN CITED2; UNCLASSIFIED DRUG;

AKAP12 GENE; ALPHA RADIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 1P; CITED2 GENE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE MAPPING; GENE SILENCING; GENOMICS; IMMUNOBLOTTING; MALE; NONHUMAN; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIATION CARCINOGENESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

A KINASE ANCHOR PROTEINS; ANIMALS; BONE NEOPLASMS; CELL CYCLE PROTEINS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; NEOPLASMS, RADIATION-INDUCED; OSTEOSARCOMA; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS;

RATTUS;

EID: 70449705839     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.022     Document Type: Article

References (23)

1. Wong F.L., Boice Jr. J.D., Abramson D.H., Tarone R.E., Kleinerman R.A., Stovall M., Goldman M.B., Seddon J.M., Tarbell N., Fraumeni Jr. J.F., and Li F.P. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278 (1997) 1262-1267
2. Porter D.E., Holden S.T., Steel C.M., Cohen B.B., Wallace M.R., and Reid R. A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. J Bone Joint Surg. Br. 74 (1992) 883-886
3. Helman L.J., and Meltzer P. Mechanisms of sarcoma development. Nat. Rev. Cancer 3 (2003) 685-694
4. Sandberg A.A., and Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet. Cytogenet. 145 (2003) 1-30
5. Koshy M., Paulino A.C., Mai W.Y., and Teh B.S. Radiation-induced osteosarcomas in the pediatric population. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 1169-1174
6. Rowland R.E., Stehney A.F., and Lucas Jr. H.F. Dose-response relationships for female radium dial workers. Radiat. Res. 76 (1978) 368-383
7. Koshurnikova N.A., Gilbert E.S., Sokolnikov M., Khokhryakov V.F., Miller S., Preston D.L., Romanov S.A., Shilnikova N.S., Suslova K.G., and Vostrotin V.V. Bone cancers in Mayak workers. Radiat. Res. 154 (2000) 237-245
8. Nekolla E.A., Kreisheimer M., Kellerer A.M., Kuse-Isingschulte M., Gossner W., and Spiess H. Induction of malignant bone tumors in radium-224 patients: risk estimates based on the improved dosimetry. Radiat. Res. 153 (2000) 93-103
9. Rosemann M., Lintrop M., Favor J., and Atkinson M.J. Bone tumorigenesis induced by alpha-particle radiation: mapping of genetic loci influencing predisposition in mice. Radiat. Res. 157 (2002) 426-434
10. Volf V., Luz A., Schaffer E., Muller W.A., and Rencova J. Effect of oral ZnDTPA on late effects of injected plutonium in rat. Int. J. Radiat. Biol. 75 (1999) 929-941
11. 239Pu citrate. J. Radiat. Res. (Tokyo) 44 (2003) 125-132
12. Daino K., Ugolin N., Altmeyer-Morel S., Guilly M.N., and Chevillard S. Gene expression profiling of alpha-radiation-induced rat osteosarcomas: identification of dysregulated genes involved in radiation-induced tumorigenesis of bone. Int. J. Cancer 125 (2009) 612-620
13. Wong G., and Cohn D.V. Separation of parathyroid hormone and calcitonin-sensitive cells from non-responsive bone cells. Nature 252 (1974) 713-715
14. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
15. Lin X., Nelson P.J., Frankfort B., Tombler E., Johnson R., and Gelman I.H. Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras. Mol. Cell. Biol. 15 (1995) 2754-2762
16. Xia W., Unger P., Miller L., Nelson J., and Gelman I.H. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res. 61 (2001) 5644-5651
17. Choi M.C., Jong H.S., Kim T.Y., Song S.H., Lee D.S., Lee J.W., Kim T.Y., Kim N.K., and Bang Y.J. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 23 (2004) 7095-7103
18. Mori Y., Cai K., Cheng Y., Wang S., Paun B., Hamilton J.P., Jin Z., Sato F., Berki A.T., Kan T., Ito T., Mantzur C., Abraham J.M., and Meltzer S.J. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131 (2006) 797-808
19. Jin Z., Hamilton J.P., Yang J., Mori Y., Olaru A., Sato F., Ito T., Kan T., Cheng Y., Paun B., David S., Beer D.G., Agarwal R., Abraham J.M., and Meltzer S.J. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 111-117
20. Bai L., and Merchant J.L. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett. 581 (2007) 5904-5910
21. Leung M.K., Jones T., Michels C.L., Livingston D.M., and Bhattacharya S. Molecular cloning and chromosomal localization of the human CITED2 gene encoding p35srj/Mrg1. Genomics 61 (1999) 307-313
22. Seidman J.G., and Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough. J. Clin. Invest. 109 (2002) 451-455
23. MacDonald S.T., Bamforth S.D., Chen C.M., Farthing C.R., Franklyn A., Broadbent C., Schneider J.E., Saga Y., Lewandoski M., and Bhattacharya S. Epiblastic Cited2 deficiency results in cardiac phenotypic heterogeneity and provides a mechanism for haploinsufficiency. Cardiovasc. Res. 79 (2008) 448-457